Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT06855524
What this trial is testing

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer

Who this might be right for
Malignant Digestive System NeoplasmMalignant Female Reproductive System NeoplasmBreast Carcinoma+2 more
Mayo Clinic 34
Testing effectiveness (Phase 2)Looking for participantsNCT07630974
What this trial is testing

Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 134
Not applicableUnknownNCT06512896
What this trial is testing

Clinical Study on Intraluminal Injection of FOLactis

Who this might be right for
Solid TumorImmune ResponsePleural Effusion, Malignant+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272590
What this trial is testing

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 290
Early research (Phase 1)Study completedNCT02675491
What this trial is testing

Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT01243762
What this trial is testing

Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Who this might be right for
Neoplasms Malignant
Merck Sharp & Dohme LLC 47
Not applicableStudy completedNCT04870320
What this trial is testing

Study of Attention and Memory Treatments for Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 49
Early research (Phase 1)Looking for participantsNCT07100210
What this trial is testing

A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity

Who this might be right for
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
Xingchen Peng 6
Not applicableLooking for participantsNCT05068583
What this trial is testing

Liquid Biopsies in Pediatric Solid Tumors

Who this might be right for
Pediatric Solid Tumor, Unspecified, Protocol Specific
Children's Hospital Los Angeles 320
Early research (Phase 1)Study completedNCT04126668
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

Who this might be right for
Advanced Malignant Solid Tumors
AnewPharma 24
Not applicableActive Not RecruitingNCT07387874
What this trial is testing

A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors

Who this might be right for
Recurrent or Metastatic Solid Tumors
Lixiaoling 30
Testing effectiveness (Phase 2)Looking for participantsNCT07326488
What this trial is testing

MHB009C in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Early research (Phase 1)UnknownNCT04275050
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets

Who this might be right for
Advanced Malignant Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT01648764
What this trial is testing

LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

Who this might be right for
Malignant Solid TumorSolid TumorMetastatic Tumor
Eli Lilly and Company 73
Early research (Phase 1)UnknownNCT05499715
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Advanced Tumor of Digestive Tract or Urinary System
Chinese Academy of Medical Sciences 48
Early research (Phase 1)UnknownNCT05730361
What this trial is testing

Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors

Who this might be right for
Digestive System Malignant Solid Tumors
Peking University 48
Next Page